IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...
GlobalData on MSN
Edwards reports strong 2025 despite Q4 EPS miss
Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.
WASHINGTON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced significant additions to the body of high-quality evidence presented and published during the Transcatheter Cardiovascular ...
The Centers for Medicare & Medicaid Services have finalized a new National Coverage Determination for tricuspid transcatheter edge-to-edge repair (T-TEER) in patients suffering from symptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results